Obesity drugs in kindergarten? Novo Nordisk GLP-1 drug works for kids as young as 6, study finds. 

By / / Finance / 1 minute of reading




Amid an ongoing debate over what role, if any, GLP-1 medications should play in treating children who are still in elementary school, researchers have concluded that a Novo Nordisk obesity drug may be safe and effective for kids as young as 6 years of age.



Source link

About The Author

Avatar of Lisa Ferguson
Lisa Ferguson is an award-winning writer and editor who is passionate about politics, health, business, and finance. In her free time, Lisa loves to read nonfiction books and watch documentaries about current affairs. Her favorite subjects are health care policy, climate change, and social justice issues like immigration reform.

Start typing and press enter to search

Scroll to Top